New Insights and Unresolved Issues Regarding Insertional Mutagenesis in X-linked SCID Gene Therapy
Open Access
- 1 November 2007
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (11) , 1910-1916
- https://doi.org/10.1038/sj.mt.6300297
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Gene therapy for severe combined immunodeficiency: are we there yet?Journal of Clinical Investigation, 2007
- Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicityBlood, 2006
- Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cellsBlood, 2005
- Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cellsBlood, 2005
- Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene MarkingScience, 2005
- Insertion of Retroviral Vectors in NOD/SCID Repopulating Human Peripheral Blood Progenitor Cells Occurs Preferentially in the Vicinity of Transcription Start Regions and in IntronsMolecular Therapy, 2004
- A new modality for immunosuppression: targeting the JAK/STAT pathwayNature Reviews Drug Discovery, 2004
- Second Child in French Trial Is Found to Have LeukemiaScience, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Murine Leukemia Induced by Retroviral Gene MarkingScience, 2002